Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
Viruses. 2020 Dec 5;12(12):1394. doi: 10.3390/v12121394.
Viruses. 2020.
PMID: 33291455
Free PMC article.
Vidofludimus calcium, a next generation DHODH inhibitor for the Treatment of relapsing-remitting multiple sclerosis.
Muehler A, Peelen E, Kohlhof H, Gröppel M, Vitt D.
Muehler A, et al. Among authors: groppel m.
Mult Scler Relat Disord. 2020 Aug;43:102129. doi: 10.1016/j.msard.2020.102129. Epub 2020 May 6.
Mult Scler Relat Disord. 2020.
PMID: 32428844
Free article.
Item in Clipboard
Cite
Cite